References
- Akaoka H, Aston-Jones G. (1993). Indirect serotonergic agonists attenuate neuronal opiate withdrawal. Neuroscience 54:561–5
- Calapai G, Crupi A, Firenzuoli F, et al. (1999). Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat. J Pharm Pharmacol 51:723–8
- Chatterjee SS, Bhattacharya SK, Wonnemann M, et al. (1998). Antidepressant activity of Hypericum perforatum and hyperforin: The neglected possibility. Pharmacopsychiatry 31:7–15
- Feily A, Abbasi N. (2009). The inhibitory effect of Hypericum perforatum extract on morphine withdrawal syndrome in rat and comparison with clonidine. Phytother Res 23:1549–52
- Franklin M, Cowen PJ. (2001). Researching the antidepressant actions of Hypericum perforatum (St. John's wort) in animals and man. Pharmacopsychiatry 34:29–37
- Misane I, Ogren SO. (2001). Effects of Hypericum perforatum (St. John's wort) on passive avoidance in the rat: Evaluation of potential neurochemical mechanisms underlying its antidepressant activity. Pharmacopsychiatry 34:89–97
- National Research Council. (1996). Guide for the Care and Use of Laboratory Animals. Washington, USA: National Academy Press, 1–7
- Nathan P. (1999). The experimental and clinical pharmacology of St. John's Wort (Hypericum perforatum L). Mol Psych 4:333–8
- Raffa RB. (1998). Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals [sigma] receptor binding. Life Sci 62:PL265–PL70
- Rossby SP, Perrin C, Burt A, et al. (1996). Fluoxetine increase steady state levels of preproenkephalin mRNA in rat amygdala by a serotonin dependent mechanism. J Serotonin Res 3:69–74
- Samanin R, Cervo L, Rochat C, et al. (1980). Reduction in the number of serotonin receptors in the brainstem of morphine dependent rats: Relation to blockade of naloxone precipitated jumping by serotonin agonists. Life Sci 27:1141–6
- Sewell RDE. (1991). Supraspinal and spinal monoamine-modified function and the expression of opioid antinociception. J Psychopharmacol 5:352–9
- Simmen U, Schweitzer C, Burkard W, et al. (1998). Hypericum perforatum inhibits the binding of mu- and kappa-opioid receptor expressed with the Semliki Forest virus system. Pharm Acta Helv 73:53–6
- Subhan F, Pache DM, Sewell RDE. (2000). CCK2 receptor antagonism attenuates negative motivational properties and physical signs of morphine withdrawal. Pharmacol Rev Comm 11:27–38
- Subhan F, Khan M, Ibrar M, et al. (2007). Antagonism of antinociceptive effect of hydro-ethanolic extract of Hypericum perforatum Linn. by a non selective opioid receptor antagonist, naloxone. Pak J Biol Sci 10:792–6
- Subhan F, Khan N, Sewell RDE. (2009). Adulterant profile of illicit street heroin and reduction of its precipitated physical dependence withdrawal syndrome by extracts of St John's wort (Hypericum perforatum). Phytother Res 23:564–71
- Williamson EM, Okpako DT, Evans FJ. (1998). Selection, Preparationand Pharmacological Evaluation of Plant Material. Chichester, UK: John Wiley & Sons, 15–23